XML 38 R31.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Restatement of Previously Issued Consolidated Financial Statements (Tables)
6 Months Ended
Jun. 30, 2024
Prior Period Adjustment [Abstract]  
Summary of Impact of Correction of Misstatements

The impact of the correction of the misstatements is summarized below (in thousands):

 

 

As of June 30, 2023

 

Corrected Condensed Consolidated Balance Sheets (Unaudited)

 

As Previously Reported

 

 

Restatement Impact

 

 

As Restated

 

Warrant liabilities

 

 

 

 

 

56,181

 

 

 

56,181

 

Total liabilities

 

 

6,836

 

 

 

56,181

 

 

 

63,017

 

Common stock

 

 

23

 

 

 

 

 

 

23

 

Additional paid-in capital

 

 

323,142

 

 

 

 

 

 

323,142

 

Accumulated deficit

 

 

(223,216

)

 

 

(56,181

)

 

 

(279,397

)

Total Stockholders' Equity

 

$

99,949

 

 

$

(56,181

)

 

$

43,768

 

 

 

 

 

For the Three Months Ended
June 30, 2023

 

 

For the Six Months Ended
June 30, 2023

 

Corrected Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

 

As
Previously
Reported

 

 

Restatement
Impact

 

 

As
Restated

 

 

As
Previously
Reported

 

 

Restatement
Impact

 

 

As
Restated

 

Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds

 

 

 

 

 

(56,181

)

 

 

(56,181

)

 

 

 

 

 

(56,181

)

 

 

(56,181

)

Net loss and comprehensive loss

 

$

(9,579

)

 

$

(56,181

)

 

$

(65,760

)

 

$

(20,351

)

 

$

(56,181

)

 

$

(76,532

)

Net loss per share, basic and diluted

 

$

(0.40

)

 

$

(2.34

)

 

$

(2.74

)

 

$

(1.06

)

 

$

(2.93

)

 

$

(3.99

)

 

 

 

 

For the Six Months Ended June 30, 2023

 

 

 

Accumulated Deficit

 

 

Total Stockholders' Equity

 

Corrected Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

 

As
Previously
Reported

 

 

Restatement
Impact

 

 

As
Restated

 

 

As
Previously
Reported

 

 

Restatement
Impact

 

 

As
Restated

 

Balance as of December 31, 2022

 

$

(202,865

)

 

$

 

 

$

(202,865

)

 

$

84,183

 

 

$

 

 

$

84,183

 

Stock-based compensation

 

 

 

 

 

 

 

 

 

 

 

1,381

 

 

 

 

 

 

1,381

 

Net loss and comprehensive loss

 

 

(10,772

)

 

 

 

 

 

(10,772

)

 

 

(10,772

)

 

 

 

 

 

(10,772

)

Balance as of March 31, 2023

 

$

(213,637

)

 

$

 

 

$

(213,637

)

 

$

74,792

 

 

$

 

 

$

74,792

 

Issuance of common stock and pre-funded warrants in connection with Securities Purchase Agreement, net of issuance costs

 

 

 

 

 

 

 

 

 

 

 

33,017

 

 

 

 

 

 

33,017

 

Stock-based compensation

 

 

 

 

 

 

 

 

 

 

 

1,720

 

 

 

 

 

 

1,720

 

Net loss and comprehensive loss

 

 

(9,579

)

 

 

(56,181

)

 

 

(65,760

)

 

 

(9,579

)

 

 

(56,181

)

 

 

(65,760

)

Balance as of June 30, 2023

 

$

(223,216

)

 

$

(56,181

)

 

$

(279,397

)

 

$

99,949

 

 

$

(56,181

)

 

$

43,768

 

 

 

 

 

For the Six Months Ended June 30, 2023

 

Corrected Condensed Consolidated Statements of Cash Flows (Unaudited)

 

As Previously Reported

 

 

Restatement Impact

 

 

As Restated

 

Net loss

 

$

(20,351

)

 

$

(56,181

)

 

$

(76,532

)

Change in fair value of warrant liabilities and fair value of financial instruments issued in excess of proceeds

 

 

 

 

 

56,181

 

 

 

56,181

 

Net cash used in operating activities

 

$

(18,145

)

 

$

 

 

$

(18,145

)